Neglected gut microbiome: interactions of the non-bacterial gut microbiota with enteric pathogens

Abstract

A diverse array of commensal microorganisms inhabits the human intestinal tract. The most abundant and most studied members of this microbial community are undoubtedly bacteria. Their important role in gut physiology, defense against pathogens, and immune system education has been well documented over the last decades. However, the gut microbiome is not restricted to bacteria. It encompasses the entire breadth of microbial life: viruses, archaea, fungi, protists, and parasitic worms can also be found in the gut. While less studied than bacteria, their divergent but important roles during health and disease have become increasingly more appreciated. This review focuses on these understudied members of the gut microbiome. We will detail the composition and development of these microbial communities and will specifically highlight their functional interactions with enteric pathogens, such as species of the family Enterobacteriaceae . The interactions can be direct through physical interactions, or indirect through secreted metabolites or modulation of the immune response. We will present general concepts and specific examples of how non-bacterial gut communities modulate bacterial pathogenesis and present an outlook for future gut microbiome research that includes these communities.

Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration

“… 1 While the term “gut microbiota” typically refers to the multitude of bacterial species residing in the GI tract, non-bacterial microbes, including fungi and bacteriophages, have emerged as equally important modulators of host-microbe interactions. 2 , 3 Unwarranted fluctuations in gut microbiota composition, as well as alterations in the crosstalk between the host and its microbiome—comprising the microbiota, its components and products, and the environment 4 —tend to influence disease development. The spectrum ranges from metabolic disorders 5 and inflammatory bowel disease (IBD) 6 , 7 , 8 to cancer 9 and major depressive disorders.…”

Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?

“…Justification: The gut microbiome should be considered a complex community of bacteria, fungi, viruses, archaea, and parasites. 146 It would be interesting to analyze the interactions between drugs and fungi. For instance, the fungal probiotic Saccharomyces boulardii CNCM I-745 is resistant to antibiotics because of its natural fungal properties.…”

Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases

“…Human gut fungi may also play a role in interacting with H. pylori. Candida, a common genus of fungi in the human microbiota, was known to be able to harbor H. pylori [28]. Currently, relatively little is known about how H. pylori infection changes gut mycobiota composition.…”